Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Bladder Cancer”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Not applicableNot Yet RecruitingNCT07817173
What this trial is testing

Feasibility of HISA During TURBT for NMIBC

Who this might be right for
Bladder CancerBladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)Non-muscle Invasive Bladder Cancer (NMIBC)+6 more
CAMC Health System 40
Testing effectiveness (Phase 2)Study completedNCT03473574
What this trial is testing

Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients

Who this might be right for
CholangiocarcinomaGall Bladder CarcinomaCholangiocarcinoma Non-resectable+1 more
AIO-Studien-gGmbH 128
Early research (Phase 1)Study completedNCT02053220
What this trial is testing

Mechanism of Action Trial of ColoAd1

Who this might be right for
Resectable Colon CancerResectable Non-small Cell Lung CancerResectable Bladder Cancer+1 more
Akamis Bio 17
Large-scale testing (Phase 3)Looking for participantsNCT06712420
What this trial is testing

Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)

Who this might be right for
Gall Bladder Carcinoma
Rajiv Gandhi Cancer Institute & Research Center, India 114
Testing effectiveness (Phase 2)UnknownNCT04730232
What this trial is testing

Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable

Who this might be right for
High-RiskNon-Muscle Invasive Bladder Urothelial Carcinoma
Tianjin Medical University Second Hospital 63
Not applicableNot Yet RecruitingNCT07454486
What this trial is testing

TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort

Who this might be right for
Biliary Tract Cancer (BTC)Biliary Tract Cancer (CCA)Gall Bladder Cancer+11 more
Aarhus University Hospital 300
Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Testing effectiveness (Phase 2)Study completedNCT01118897
What this trial is testing

Tomotherapy in Locally Advanced Gallbladder and Pancreatic Cancers

Who this might be right for
Pancreatic Neoplasms MalignantMalignant Neoplasm of Gall Bladder Non-resectable
Tata Memorial Hospital 60
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT01108055
What this trial is testing

Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer

Who this might be right for
Bladder CancerBladder (Urothelial, Transitional Cell) CancerBladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)+2 more
Sandy Srinivas 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06588179
What this trial is testing

SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt

Who this might be right for
NMIBC
Fudan University 58
Testing effectiveness (Phase 2)Ended earlyNCT03498196
What this trial is testing

A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerMetastatic Bladder CancerInvasive Bladder Cancer
Baylor College of Medicine 1
Testing effectiveness (Phase 2)Study completedNCT03534492
What this trial is testing

Durvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB)

Who this might be right for
Bladder Cancer
Spanish Oncology Genito-Urinary Group 29
Testing effectiveness (Phase 2)UnknownNCT05495724
What this trial is testing

Disitamab Vedotin Combined With Tislelizumab for Her2 Overexpressing High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable

Who this might be right for
Her2 Overexpressing High-Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
Tianjin Medical University Second Hospital 176
Early research (Phase 1)Study completedNCT03387761
What this trial is testing

Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy

Who this might be right for
Urothelial Carcinoma
The Netherlands Cancer Institute 54
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Large-scale testing (Phase 3)Not Yet RecruitingNCT07608224
What this trial is testing

HOPE-07-MIBC: Disitamab Vedotin Plus Immunotherapy vs Chemoimmunotherapy in Resectable HER2-Expressing MIBC

Who this might be right for
Urinary Bladder Neoplasms
West China Hospital 240
Large-scale testing (Phase 3)Enrolling By InvitationNCT06671418
What this trial is testing

Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary Obstruction

Who this might be right for
Cholangiocarcinoma Non-resectableGall Bladder CancerLiver Metastasis+1 more
Erasmus Medical Center 148
Testing effectiveness (Phase 2)Ended earlyNCT00268450
What this trial is testing

Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery

Who this might be right for
Bladder Cancer
Medical University of South Carolina 21
Not applicableWithdrawnNCT01060319
What this trial is testing

A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies

Who this might be right for
Bladder CancerSkin CancersBladder (Urothelial, Transitional Cell) Cancer+1 more
Stanford University
Next Page